GONAL-F follitropin alfa (rch) 900IU /1.5mL (65.52microgram) solution for injection cartridge, pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

gonal-f follitropin alfa (rch) 900iu /1.5ml (65.52microgram) solution for injection cartridge, pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: poloxamer; phosphoric acid; sucrose; dibasic sodium phosphate dihydrate; water for injections; methionine; metacresol; sodium hydroxide; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

GONAL-F follitropin alfa (rch) 450IU /0.75mL (32.76microgram) solution for injection cartridge, pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

gonal-f follitropin alfa (rch) 450iu /0.75ml (32.76microgram) solution for injection cartridge, pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: methionine; phosphoric acid; dibasic sodium phosphate dihydrate; sodium hydroxide; poloxamer; sucrose; metacresol; water for injections; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

GONAL-F follitropin alfa (rch) 300IU /0.5mL (21.84microgram) solution for injection cartridge, pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

gonal-f follitropin alfa (rch) 300iu /0.5ml (21.84microgram) solution for injection cartridge, pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 600 iu/ml - injection, solution - excipient ingredients: methionine; phosphoric acid; dibasic sodium phosphate dihydrate; water for injections; sucrose; poloxamer; sodium hydroxide; metacresol; monobasic sodium phosphate monohydrate - the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated. for controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies. gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

THROMBIN HUMAN powder, for solution United States - English - NLM (National Library of Medicine)

thrombin human powder, for solution

ethicon, inc - human thrombin (unii: 6k15abl77g) (human thrombin - unii:6k15abl77g) - human thrombin 2000 [iu] in 2 ml - evithrom® thrombin, topical (human), is indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. evithrom® thrombin, topical (human), may be used in conjunction with an absorbable gelatin sponge, usp. - do not use in individuals known to have an anaphylactic or severe systemic reaction to evithrom® or to human blood products. - do not use for the treatment of severe or brisk arterial bleeding. risk summary there are no data with evithrom® use in pregnant women to inform a drug-associated risk. animal reproduction studies have not been conducted with evithrom® . it is not known whether evithrom® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. evithrom® should be given to a pregnant woman only if clearly needed. in the u.s. general population, the estimated background

HUMAN PARVOVIRUS HOMOCHORD- parvovirus nosode liquid United States - English - NLM (National Library of Medicine)

human parvovirus homochord- parvovirus nosode liquid

deseret biologicals, inc. - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

HUMAN PARVOVIRUS REMEDY- parvovirus nosode (b19) liquid United States - English - NLM (National Library of Medicine)

human parvovirus remedy- parvovirus nosode (b19) liquid

deseret biologicals, inc - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 [hp_x] in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

HUMAN PARVOVIRUS REMEDY- parvovirus liquid United States - English - NLM (National Library of Medicine)

human parvovirus remedy- parvovirus liquid

apotheca company - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 [hp_x] in 1 ml -     indications:  for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever. indications:   for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.

HUMAN ALBUMIN 20% Infusion Kenya - English - Pharmacy and Poisons Board

human albumin 20% infusion

human albumin 20% - infusion - human albumin 20% - albumin